Featured Courses

Relapsed/Refractory Multiple Myeloma: What’s Next for Patients? | myCME

AMA PRA Category 1 Credit(s)^TM, CE for Pharmacists, ABIM MOC Points

Though treatable, multiple myeloma (MM) remains incurable. Patients inevitably experience relapse or develop resistance to initial multidrug combinations in spite of high complete response (CR) rates. The growing number of novel agents holds increasing promise of benefit for patients who relapse and/or become refractory to therapy, but improving the prognosis for these patients requires clinicians to adjust their therapeutic strategies based on the availability of these agents.

EXPLORING ALL POSSIBILITIES: Improving Outcomes for Adolescents and Young Adults With Acute Lymphoblastic Leukemia | myCME

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s), AANP Contact Hour(s)

This 60-minute online activity features a tumor board-like discussion by an interprofessional faculty team who present two patient cases and explore treatment regimens for adolescents and young adults with acute lymphoblastic leukemia (ALL).

Hematology Consults: Acute & Chronic GVHD – Module 2 | myCME

AMA PRA Category 1 Credit(s)^TM, CNE Contact Hour(s)

There is little guidance about choosing the most appropriate therapy for patients with graft vs host disease (GVHD) after undergoing an allogeneic hematopoietic stem cell transplantation (alloHSCT). Until the recently, steroids were the only agents with proven ability to treat patients with GVHD.

Oral Therapy for Outpatient Management of Multiple Myeloma: Options for the COVID-19 Era | myCME

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s)

In this webcast, a panel of renowned clinical MM experts provides timely support and guidance to oncology HCPs on how to respond to the needs of MM patients in the current COVID-19 public health emergency.

Navigation 101 | myCME

CNE Contact Hour(s)

Oncology nurse navigation is a supportive service offered to cancer patients and their families. ONNs will need to be able to distinguish roles/responsibilities of the ONN in comparison to other members of the oncology care team and understand the core competencies necessary to successfully fill the role of an Oncology Nurse Navigator.

Tailoring Treatment Plans for Adults with AML: Expert Guidance on Integrating the Latest Advances | myCME

AMA PRA Category 1 Credit(s)^TM

4 interactive patient cases that enable clinicians to evaluate and integrate expert guidance when tailoring frontline treatment plans.

Treatment Options for Multiple Myeloma Patients Who Have Relapsed From or Are Refractory to Multiple Therapies | myCME

AMA PRA Category 1 Credit(s)^TM, CNE Contact Hour(s), ABIM MOC Points

This CME/CNE-certified webinar will help oncology health care providers deliver the best possible care to patients with MM and keep up with the rapid advancements in treatments relating to current and new agents in the relapsed/refractory setting.

Delivering Personalized Care Across the AML Disease Spectrum | myCME

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s), CE for Pharmacists

This activity will provide practical guidance and recommendations for personalized AML therapy at the optimal treatment stage—induction, maintenance, or salvage—to ensure optimal patient outcomes.

The Role of Maintenance Therapy in AML | myCME

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s), CE for Pharmacists

As the research of maintenance strategies in acute myeloid leukemia (AML) advances, it is important for clinicians stay abreast of study designs and results from clinical trials. This activity will discuss a patient case study and explain treatment decisions and rationale for maintenance strategies in AML.

Role of the Navigator in Advance Care Planning | myCME

CNE Contact Hour(s)

The value of advanced care planning is now being increasingly recognized as an imperative part of any treatment plan for chronic disease. This has never been more important that now; in the midst of the Covid 19 pandemic where patients are being faced with end of life before they had planned.

Navigation Strategies for Chimeric Antigen Receptor T-Cell (CAR-T) Therapy and Hematologic Cancers | myCME

CNE Contact Hour(s)

This program will discuss strategies to better navigate patients through their CAR-T therapy care plans and best practices on how to transition to community oncologists for post-treatment and long-term survivorship care.

Standards and Accreditation: How to Improve Navigation and Survivorship | myCME

CNE Contact Hour(s)

Discuss standards and Accreditation as the oncology nurse navigator is a specialized source for evidence-based information for cancer patients and their families. And how the ONN contributes to cancer care outcomes.